Lufran Pharma Private Limited
About Lufran Pharma Private Limited
Data last updated:
Lufran Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 17 November 2023.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U46497UP2023PTC192572.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar Bansal and Ragini Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lucknow, Uttar Pradesh.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lufran Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered Address10/1, Havelock Road, Lucknow, Uttar Pradesh, India – 226001
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Lufran Pharma Private Limited
FY 2025 filings availableLufran Pharma Private Limited reported revenue of ₹740 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Lufran Pharma Private Limited, buy the company report.
Board of directors of Lufran Pharma Private Limited
Lufran Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Bansal | Director | 17 Nov 2023 | 2 Years 11 Months | Current |
| Ragini Bansal Also directs: Indven Pharma Private Limited, MCRC Trading Private Limited | Director | 17 Nov 2023 | 2 Years 11 Months | Current |
Peer comparison
Lufran Pharma Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hans Pharmaceutical and Chemicals Private Limited | ₹1,000 (FY 2019) | Uttar Pradesh, India | ||||
| Reckitt Piramal Private Limited | ₹1,000 (FY 2025) | -100.0% | Mumbai, Maharashtra, India | |||
| Elyon Health Care Private Limited | ₹899 (FY 2024) | 6.0% | Navi Mumbai, Maharashtra, India | |||
| Admac Lifesciences Limited | ₹764 (FY 2024) | Panchkula, Haryana, India | ||||
| Hathway Wellness Private Limited | ₹752 (FY 2024) | Nagpur, Maharashtra, India | ||||
| Lufran Pharma Private Limitedthis company | ₹740 (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Rangacharya Industries Private Limited | ₹650 (FY 2024) | Navi Mumbai, Maharashtra, India | ||||
| Ochoa Laboratories Limited | ₹605 (FY 2025) | New Delhi, Delhi, India | ||||
| Maitri Healthcare and Traders Private Limited | ₹604 (FY 2017) | -98.0% | Ahmedabad, Gujarat, India | |||
| Samudera Industries Limited | ₹600 (FY 2016) | Kanjurmarg West, Maharashtra, India | ||||
| Biochem Pharmaceutical Private Limited | ₹600 (FY 2025) | -40.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Lufran Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lufran Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lufran Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Lufran Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Lufran Pharma Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Anil Kumar Bansal was appointed as Director on 17 Nov 2023.
Frequently asked questions
Lufran Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. It was incorporated on 17 November 2023 (3+ years old) and is registered under CIN U46497UP2023PTC192572.
Lufran Pharma has 2 current directors:
- Anil Kumar Bansal - Director
- Ragini Bansal - Director
The latest financial statements of Lufran Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Lufran Pharma is U46497UP2023PTC192572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lufran Pharma was incorporated on 17 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Lufran Pharma by revenue are Hans Pharmaceutical and Chemicals Private Limited, Reckitt Piramal Private Limited, Elyon Health Care Private Limited, Admac Lifesciences Limited, Hathway Wellness Private Limited and 5 more, all in the Pharma industry (Formulations).
Anil Kumar Bansal was appointed as Director on 17 Nov 2023. Ragini Bansal was appointed as Director on 17 Nov 2023.
The registered office of Lufran Pharma is at 101, Havelock Road, Lucknow, Uttar Pradesh, India – 226001.
The compliance status of Lufran Pharma is compliant as of 02 July 2026. The company is actively filing with the Registrar of Companies.
Lufran Pharma can be reached at its registered office: 101, Havelock Road, Lucknow, Uttar Pradesh, India – 226001.
Lufran Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.